Rigel Pharmaceuticals
Price & Volume
Stats
See moreOpen | $44.20 |
Previous Close | $44.64 |
Day Range | $42.78-$44.20 |
52W Range | $15.50-$52.24 |
Market Cap | $810.2M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $282M |
Revenue Growth (YoY) | 25.6% |
Gross Profit (12 Mos) | $234.3M |
Diluted EPS | $6.19 |
News
See moreYahoo Finance • 19 days ago
Rigel's R289 Shows Promising RBC Transfusion Independence In Phase 1b Trial In Lower-Risk MDS
Yahoo Finance • last month
Eli Lilly Partner And Cancer Treatment Maker Nears Buy Point
Yahoo Finance • 2 months ago
Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats
Yahoo Finance • 2 months ago
After-Hours Gainers: VCYT, RIGL, NPCE, CDNA, And FBLG Post Notable Moves Following Q3 Results
About
CEO | Mr. Raul R. Rodriguez |
CFO | Mr. Dean L. Schorno CPA |
Address | 611 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 162 |
